Lilly(Eli) & Company

NYSE: LLY
$921.72
+$6.68 (+0.7%)
Closing Price on September 20, 2024

LLY Articles

Eli Lilly spin-off Elanco Animal Health has amended its filing with the SEC regarding its initial public offering.
The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks was mixed.
Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team at Bank of America Merrill Lynch.
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Animal health company Elanco Animal Health has filed with the SEC regarding its initial public offering.
The top analyst upgrades, downgrades and other research calls from Wednesday include Broadcom, China Life, Crocs, Eli Lilly, Lockheed Martin, Philip Morris, Rio Tinto and Spotify.
The July 13 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
24/7 Wall St. has put together a preview of AbbVie, Eli Lilly, Gilead Sciences and some of the other, larger health care companies that are about to report their quarterly results.
Four pharmaceutical industry leaders are poised to report second-quarter results next week, and one key analyst sees the relatively good print from Johnson & Johnson as a good signal for the...
Pfizer and Eli Lilly shares were largely unaffected after the firms announced positive results from a joint late-stage trial in patients with osteoarthritis pain.
The June 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
The June 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Analysts at Jefferies have come up with a list of four pharmaceuticals stocks that may be good investments for a time of uncertainty in global markets.
Keep in mind that short sellers betting against big pharma are taking on an added risk. They have to pay out the ongoing high dividends on top of the cost of borrowing the shares.
The top analyst upgrades, downgrades and other research calls from Friday include ConocoPhillips, Domino's Pizza, Eli Lilly, Occidental Petroleum, PayPal and Penn National Gaming.